Ethyl β-carboline-3-carboxylate targets PRDX5/c-Jun axis for novel therapeutic strategy against cervical cancer.

Xiao WQ, Lee DH, Kim H, Zhang HN, Feng YY, Jin YH, Jin MH, Han YH, Kwon T, Sun HN

DOI: 10.1007/s12672-025-03306-4
Published: 2025 Aug 7
Container: Discover oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12672-025-03306-4,
  title = {Ethyl β-carboline-3-carboxylate targets PRDX5/c-Jun axis for novel therapeutic strategy against cervical cancer.},
  author = {Xiao WQ and Lee DH and Kim H and Zhang HN and Feng YY and Jin YH and Jin MH and Han YH and Kwon T and Sun HN},
  year = {2025},
  journal = {Discover oncology},
  doi = {10.1007/s12672-025-03306-4},
  url = {https://doi.org/10.1007/s12672-025-03306-4}
}

RIS

TY  - JOUR
TI  - Ethyl β-carboline-3-carboxylate targets PRDX5/c-Jun axis for novel therapeutic strategy against cervical cancer.
AU  - Xiao WQ
AU  - Lee DH
AU  - Kim H
AU  - Zhang HN
AU  - Feng YY
AU  - Jin YH
AU  - Jin MH
AU  - Han YH
AU  - Kwon T
AU  - Sun HN
PY  - 2025
JO  - Discover oncology
DO  - 10.1007/s12672-025-03306-4
UR  - https://doi.org/10.1007/s12672-025-03306-4
ER  -

APA

WQ, X., DH, L., H, K., HN, Z., YY, F., YH, J., MH, J., YH, H., T, K., & HN, S. (2025). Ethyl β-carboline-3-carboxylate targets PRDX5/c-Jun axis for novel therapeutic strategy against cervical cancer.. Discover oncology. https://doi.org/10.1007/s12672-025-03306-4

Source records

pubmed · retrieved 2026-09-26T21:20:58.909Z